BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24901363)

  • 1. Histone modifications are associated with transcript isoform diversity in normal and cancer cells.
    Podlaha O; De S; Gonen M; Michor F
    PLoS Comput Biol; 2014 Jun; 10(6):e1003611. PubMed ID: 24901363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential transcript isoform usage pre- and post-zygotic genome activation in zebrafish.
    Aanes H; Østrup O; Andersen IS; Moen LF; Mathavan S; Collas P; Alestrom P
    BMC Genomics; 2013 May; 14():331. PubMed ID: 23676078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational analysis reveals a correlation of exon-skipping events with splicing, transcription and epigenetic factors.
    Ye Z; Chen Z; Lan X; Hara S; Sunkel B; Huang TH; Elnitski L; Wang Q; Jin VX
    Nucleic Acids Res; 2014 Mar; 42(5):2856-69. PubMed ID: 24369421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors.
    Wang J; Ye Z; Huang TH; Shi H; Jin VX
    Methods Mol Biol; 2017; 1513():163-170. PubMed ID: 27807836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative start and termination sites of transcription drive most transcript isoform differences across human tissues.
    Reyes A; Huber W
    Nucleic Acids Res; 2018 Jan; 46(2):582-592. PubMed ID: 29202200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
    Wiencke JK; Zheng S; Morrison Z; Yeh RF
    Oncogene; 2008 Apr; 27(17):2412-21. PubMed ID: 17968314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
    Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK
    PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational analysis of associations between alternative splicing and histone modifications.
    Shindo Y; Nozaki T; Saito R; Tomita M
    FEBS Lett; 2013 Mar; 587(5):516-21. PubMed ID: 23353998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Alternatively Spliced Messenger RNA (mRNA) Isoforms of the Insulin-Like Growth Factor 1 (IGF1) in Selected Human Tumors.
    Kasprzak A; Szaflarski W
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development.
    Pal S; Gupta R; Kim H; Wickramasinghe P; Baubet V; Showe LC; Dahmane N; Davuluri RV
    Genome Res; 2011 Aug; 21(8):1260-72. PubMed ID: 21712398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant DNA methylation defines isoform usage in cancer, with functional implications.
    Chen YC; Elnitski L
    PLoS Comput Biol; 2019 Jul; 15(7):e1007095. PubMed ID: 31329578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter-like epigenetic signatures in exons displaying cell type-specific splicing.
    Curado J; Iannone C; Tilgner H; Valcárcel J; Guigó R
    Genome Biol; 2015 Oct; 16():236. PubMed ID: 26498677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis reveals distinct patterns of epigenetic features in long non-coding RNA loci.
    Sati S; Ghosh S; Jain V; Scaria V; Sengupta S
    Nucleic Acids Res; 2012 Nov; 40(20):10018-31. PubMed ID: 22923516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the relationship of epigenetic modifications to transcription factor binding.
    Liu L; Jin G; Zhou X
    Nucleic Acids Res; 2015 Apr; 43(8):3873-85. PubMed ID: 25820421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The epigenetic effect on pre-mRNA alternative splicing].
    Zhao J; Wang F; Xu Z; Fan Y
    Yi Chuan; 2014 Mar; 36(3):248-55. PubMed ID: 24846965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H3K4me2 functions as a repressive epigenetic mark in plants.
    Liu Y; Liu K; Yin L; Yu Y; Qi J; Shen WH; Zhu J; Zhang Y; Dong A
    Epigenetics Chromatin; 2019 Jul; 12(1):40. PubMed ID: 31266517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing.
    Li T; Liu Q; Garza N; Kornblau S; Jin VX
    Genome Med; 2018 Apr; 10(1):30. PubMed ID: 29665865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Modifications of the PGC-1α Promoter during Exercise Induced Expression in Mice.
    Lochmann TL; Thomas RR; Bennett JP; Taylor SM
    PLoS One; 2015; 10(6):e0129647. PubMed ID: 26053857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone modifications influence skipped exons inclusion.
    Hou Y; Huang H; Hu W; Liu H; Sun X
    J Bioinform Comput Biol; 2017 Feb; 15(1):1750003. PubMed ID: 28178888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3K4 demethylase KDM5B regulates global dynamics of transcription elongation and alternative splicing in embryonic stem cells.
    He R; Kidder BL
    Nucleic Acids Res; 2017 Jun; 45(11):6427-6441. PubMed ID: 28402433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.